Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $4.0B |
| Sales growthchange from the year before | -7.2% |
| Gross marginshare of sales left after the direct cost of what it sells | 20.9% |
| Operating marginshare of sales left after running the business | 1.8% |
| Net marginshare of sales kept as profit | 3.7% |
| Return on invested capitalprofit made on each $100 put into the business | 2.5% |
| Return on equityprofit vs. shareholders' accounting value | 7.1% |
| Debt / equitydebt vs. shareholders' accounting value | 0.12 |
| Change in share countnegative = the company is buying back its shares | -2.4% |
1 insider bought $250K; 1 insider sold $126K (all under pre-arranged plans) on the open market.
| Stock MichaelChief Financial Officer | Sold (plan)Aug 4 | 3,333 shat $20.00 · $67K |
| Stock MichaelChief Financial Officer | Sold (plan)Aug 3 | 3,333 shat $17.95 · $60K |
| Murti Arjun NDirector | BoughtJul 28 | 14,053 shat $17.79 · $250K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy